Business Context and Reporting Period
Company: Bristol-Myers Squibb Company
Filing Type: Form 8-K (Current Report)
Date of Report: January 29, 2004
Reporting Period: Fourth quarter of 2003 and full year 2003
This filing serves as a notification that the company has issued a press release and supplemental information regarding its financial results for the specified periods. The detailed financial data is incorporated by reference in Exhibits 99.1 and 99.2.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the referenced press release (Exhibit 99.1) and supplemental information (Exhibit 99.2), which are not included in the input text.
Material Changes
The filing text does not provide specific details regarding material changes versus prior comparable periods. Investors must refer to the incorporated exhibits for comparative analysis.
Guidance, Outlook, and Risks
The filing text does not include management commentary, future guidance, risk factors, contingencies, or unusual items. Such information is expected to be found in the referenced press release and supplemental documents.
Investor Verification Checklist
- Verify the specific revenue and net income figures for Q4 2003 and full year 2003 in Exhibit 99.1.
- Review the supplemental information in Exhibit 99.2 for segment performance and non-GAAP adjustments.
- Confirm any forward-looking statements or guidance provided in the press release.
- Check for any material changes in debt levels or liquidity positions disclosed in the full report.